|
|
|
| Research progress of mistletoe in the treatment of liver cancer |
| LIU Shuang CAO Zhengmin LYU Wenliang▲ |
| Infections Disease Section, Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Beijing 100053, China |
|
|
|
Abstract Liver cancer is one of the most harmful malignant tumors in clinic. Its morbidity and mortality rate remain high in China for a long time, which seriously affects the patients’ life, health and quality of life. In the process of prevention and treatment of liver cancer, mistletoe, as a specific drug against liver cancer, plays a huge role with its multi-channel and multi-target treatment characteristics. From the perspective of traditional Chinese medicine, mistletoe has the functions of tonifying the liver and kidney, strengthening the muscles and bones, removing wind and activating collaterals, detoxifying and eliminating carbuncle. It can cut the opportunity of liver cancer’s deficiency, toxin and stasis through the function of strengthening the body and removing pathogenic factors. From the perspective of Western medicine, mistletoe extracts, such as mistletoe agglutinin, mistletoe toxin peptide and mistletoe total base, can induce cell apoptosis and regulate the immune system liver cancer plays a certain role in the treatment. In this paper, from the perspective of the combination of traditional Chinese and Western medicine, according to the relevant literature at home and abroad in recent years, the role of mistletoe in the treatment of liver cancer is summarized to a certain extent.
|
|
|
|
|
|
[1] 李照，朱继业.《原发性肝癌诊疗规范（2017年版）》解读[J].临床肝胆病杂志，2017，33（9）：1655-1657.
[2] 杨晓东，刘兴文，李福兵，等.从本草考证论桑寄生和槲寄生[J].中药与临床，2019，10（1）：39-42.
[3] 刘志友.桑寄生、槲寄生与扁枝槲寄生的区别[J].实用中医药杂志，2018，34（7）：867.
[4] 李佳丽，颜立志，季田，等.主成分分析古医籍中肝癌类证候组方规律[J].中国中西医结合外科杂志，2016，22（6）：523-528.
[5] 钱英.槲芪方治疗原发性肝癌的临证经验[J].中西医结合肝病杂志，2019，29（2）：106-108.
[6] 靳华.钱英教授学术思想与临床经验总结及和血法治疗乙肝肝硬化代偿期的理论和临床研究[D].北京：北京中医药大学，2016.
[7] 关玥，孙长波，李慧萍，等.槲寄生的化学成分及药理作用研究进展[J].上海中医药杂志，2016，50（5）：102-105.
[8] Evans M，Bryant S，Huntley Alyson L，et al. Cancer Patients′ Experiences of Using Mistletoe （Viscum album）：A Qualitative Systematic Review and Synthesis [J]. J Altern Complement Med，2016，22（2）：134-144.
[9] 杨学良，任强，王广义.重组槲寄生凝集素抗肝癌作用[J].中国老年学杂志，2015（5）：1348-1350.
[10] 孔凡青，吕学谦，杨艳红.槲寄生抗肿瘤作用研究[J].科技信息，2010（19）：820-821.
[11] Liao Y，Yang F，Li X，et al. The impact of Caspase-8 on non-small cell lung cancer brain metastasis in Ⅱ/Ⅲ stage patient [J]. Neoplasma，2015. doi：10.4149/neo_2015_043.
[12] 杨涛，费振海，钟兴明.Caspase家族与细胞凋亡的研究进展[J].浙江医学，2018，40（18）：2083-2087，2091.
[13] 孙华，魏美娟，许均，等.槲寄生凝集素蛋白诱导肿瘤细胞凋亡的实验研究[J].中国微循环，2009，13（6）：481-484，650.
[14] El-Mazny A，Sayed M，Sharaf S. Human telomerase reverse transcriptase messenger RNA （TERT mRNA） as a tumour marker for early detection of hepatocellular carcinoma [J]. Arab J Gastroenterol，2014，15（2）：68-71.
[15] Qian YQ，Yang LL，Cao S. Telomeres and telomerase in T cells of tumor immunity [J]. Cell Immunol，2014，289（1/2）：63-69.
[16] Steinborn C，Klemd AM，Sanchez-Campillo AS，et al. Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model [J]. PLoS One，2017，12（7）：e0181553.
[17] Teral?覦 K，Yilmazer A. New surprises from an old favourite：The emergence of telomerase as a key player in the regulation of cancer stemness [J]. Biochimie，2016，121：170-178.
[18] 杨学良.重组槲寄生凝集素抗肝癌细胞SMMC7721的实验研[D].长春：吉林大学，2013.
[19] 孟霞，刘树红，李霞，等.槲芪散对肝癌前病变端粒酶活性的调控作用[J].中国比较医学杂志，2016（10）：36-42.
[20] 李若菲，王芸姣，王学江，等.中药槲芪散及槲寄生总碱、多糖抑制大鼠肝癌前病变的研究[J].中国病理生理杂志，2015（10）：1838-1839.
[21] 王鹏雁，安建多，王池，等.槲芪散及槲寄生提取物对肝癌细胞内游离钙离子浓度的影响[J].首都医科大学学报，2012，33（3）：291-296. |
|
|
|
